Last reviewed August 20, 2026 by the Medically Modern coverage team. Plan rules differ by employer and by state — confirm specifics with your own plan.
Dexcom reports that about 87% of people using insulin are covered and roughly 50% of those not using insulin are covered, and that most people with CGM coverage pay $20 a month or less. Those are Dexcom's own footnoted figures, not independent findings — but they match what we see: if you use insulin and have commercial insurance, coverage is likely. Getting it billed correctly is the part people get wrong.
The single most important question: which benefit?
Commercial plans handle the Dexcom G7® through one of two lanes, and the cost difference between them can be large.
| Pharmacy benefit | Medical / DME benefit | |
|---|---|---|
| Where you get it | Retail or mail-order pharmacy | A durable medical equipment supplier |
| What you typically pay | A flat copay per fill, often per 30 days | Coinsurance (a percentage), usually after the deductible |
| Best when | Your plan has a low, flat CGM copay | You have already met your deductible, or DME coinsurance is low |
| Common friction | Formulary preference for another CGM brand | Prior authorization and documentation requirements |
There is no universal right answer. On a plan with a $25 CGM pharmacy copay, the pharmacy lane wins easily. On a plan with a high pharmacy tier but a met deductible and 10% DME coinsurance, the medical lane wins. The only way to know is to price both — which is what a benefits check does.
We price both lanes for you
Our team checks your pharmacy and medical benefits and tells you which one is actually cheaper on your plan.
What your plan will want to see
Commercial criteria are not standardized the way Medicare's are, but most plans ask for some combination of:
- A diabetes diagnosis documented by your prescriber, with the diagnosis code on the order.
- Insulin use, or documented problematic hypoglycemia. Many commercial plans borrow Medicare's framing here — recurrent lows below 54 mg/dL, or a severe event requiring someone else's help.
- A recent office visit with the prescriber addressing your diabetes management.
- A valid prescription specifying the G7 and the supply quantity.
- Sometimes, a prior authorization submitted by the prescriber before the first fill.
Not sure whether you clear these? Our eligibility guide walks through them one at a time.
Prior authorization, in practice
Prior authorization is a request your prescriber submits asking the plan to approve the G7 before it is dispensed. It is routine, and it is also the most common place an order stalls — usually not because the plan said no, but because nobody submitted it, or it was submitted without the documentation the plan wanted.
Confirm whether your plan requires one
Call the number on your card, or have your supplier check. Requirements differ by plan and can differ by benefit lane within the same plan.
Get the clinical documentation together
Chart notes showing the diagnosis, insulin regimen or hypoglycemia history, and a recent visit. This is what approvals turn on.
Submit and track it
Turnaround is often a few business days. Ask for the reference number so nobody has to start over.
If denied, read the reason before reacting
The stated reason determines the fix, and most first denials are procedural rather than final.
Why commercial claims get denied — and what fixes each one
| Denial reason | What it usually means | The fix |
|---|---|---|
| No prior authorization on file | It was never submitted, or it expired | Prescriber submits or resubmits it |
| Insufficient documentation | Chart notes did not show insulin use or hypoglycemia clearly | Prescriber supplies specific notes and resubmits |
| Non-preferred brand | The plan's formulary prefers a different CGM | Request a formulary exception with clinical justification, or discuss the preferred device with your doctor |
| Wrong benefit billed | Sent through pharmacy when the plan covers CGMs under DME, or the reverse | Rebill through the correct lane |
| Quantity limit exceeded | More sensors requested than the plan allows per period | Match the order to the plan's limit, or request an override |
A first denial is not the end. Commercial plans must give you an appeals process, and denials on documentation grounds are frequently overturned when the prescriber submits what was missing. Ask the plan for the denial in writing and for the specific criterion you failed.
What about coupons on top of insurance?
There is no US commercial-insurance copay card for Dexcom — nothing that reduces your copay the way a drug copay card would. If you are commercially insured and your plan has not yet added the G7 to its formulary, Dexcom's Quick Start program offers $89 a month at a pharmacy as a bridge until your plan adds it. That is a bridge, not a discount on an existing benefit.
Dexcom's pharmacy savings coupon exists, but it requires you to opt out of insurance entirely for that fill — which almost never makes sense if you have real coverage. Compare the two before choosing: our cash price guide has the numbers.
Frequently asked questions
Is the Dexcom G7 covered by private insurance?
Usually, for insulin users. Dexcom reports roughly 87% of insulin users are covered and about 50% of non-insulin users. What varies is the benefit lane, prior-authorization requirements, and your copay — all of which are plan-specific.
Pharmacy or DME supplier — which is cheaper?
It depends on your plan. Pharmacy usually means a flat copay; DME usually means coinsurance after a deductible. On some plans the difference is a few dollars, on others it is hundreds. Price both before committing.
Does my plan cover the G7 15 Day?
Formularies update on their own schedules, so a plan covering the standard G7 may not have added the 15-day sensor yet. Ask specifically about the product you want rather than about “Dexcom” generally.
My plan covers a different CGM brand. Can I still get a G7?
Often, through a formulary exception. Your prescriber submits clinical justification for why the preferred device is not appropriate for you. Approval is not guaranteed, and it is worth discussing honestly with your doctor whether the preferred device would work.
What to ask when you call your insurer
If you would rather do this yourself than have a supplier do it, the call is short — but only if you ask precisely. Vague questions get vague answers. Use this:
- “Is a continuous glucose monitor covered under my pharmacy benefit, my medical benefit, or both?”
- “Is the Dexcom G7 specifically on formulary? What about the Dexcom G7 15 Day?” Ask about both by name — a plan can cover one and not the other.
- “Is prior authorization required, and what clinical criteria will you apply?”
- “What is my copay or coinsurance under each benefit, and have I met the deductible that applies?”
- “Is there a quantity limit per 30 days, and is a 90-day supply allowed?”
- “Do I have to use a specific pharmacy or supplier to be in network?”
Write down the reference number for the call and the name of the person you spoke to. If a claim is later processed differently from what you were told, that record is what gets it fixed.
Employer plans, marketplace plans and high-deductible plans
The plan type changes the arithmetic more than people expect:
- Employer-sponsored plans vary enormously because the employer chooses the benefit design. Two people at the same insurer can have completely different CGM coverage. Your plan documents, not the insurer's general policy, are what govern.
- Marketplace (ACA) plans must cover prescription drugs and devices as essential health benefits, but the specific tier, cost sharing, and formulary placement of CGMs differ by plan and by state.
- High-deductible health plans are the case where the math gets counterintuitive. Until the deductible is met you may pay the full negotiated rate, which can look worse than a cash discount card. But cash payments do not count toward the deductible, while claims run through insurance do. If you expect other medical spending this year, running the claim is often better even when the immediate price looks higher.
How an appeal actually works
A first denial is a normal step, not a verdict. Commercial plans must offer an appeals process, and the sequence is predictable:
Get the denial in writing
You are entitled to a written explanation naming the specific criterion you failed. “Not medically necessary” alone is not enough — ask which requirement was not met.
Internal appeal
Your prescriber submits the missing documentation or a letter of medical necessity. This resolves most denials, because most denials are documentation gaps rather than genuine coverage exclusions.
Peer-to-peer review
Many plans allow your prescriber to speak directly with a plan physician. This is often faster than another paper round and is worth asking for by name.
External review
If internal appeals fail, you can generally request an independent external review. Deadlines are strict — note them the day the denial arrives.
The most useful sentence in an appeal is a specific clinical fact: the insulin regimen, or a dated hypoglycemic event with the glucose reading and what was required to treat it. General statements that a CGM would be beneficial carry much less weight than a documented sub-54 mg/dL event.
Quantity limits and running out
Plans commonly cap sensors per 30 days at exactly the labeled amount — three for the standard G7, two for the G7 15 Day. That leaves no margin for a sensor that fails early, which does happen; in the G7 15 Day clearance study, 73.9% of sensors lasted the full 15 days, meaning roughly a quarter did not.
Two things help. Ask Dexcom about its replacement policy for sensors that fail before their wear time — a replacement from the manufacturer does not consume a plan-covered fill. And if early failures are frequent for you, your prescriber can request a quantity-limit override with that history documented.
Sources: Dexcom cost & coverage, Dexcom Savings Center, CMS LCD L33822 (criteria many commercial plans mirror).